Home >> Research Area >>GPCR/G protein>>5-HT Receptor>> 2-[1-(4-Piperonyl)piperazinyl]benzothiazole

2-[1-(4-Piperonyl)piperazinyl]benzothiazole

5-HT4 agonist. Also 5-HT3 antagonist CAS# 155106-73-3

2-[1-(4-Piperonyl)piperazinyl]benzothiazole

Catalog No. BCC6771----Order now to get a substantial discount!

Product Name & Size Price Stock
2-[1-(4-Piperonyl)piperazinyl]benzothiazole: 5mg $81 In Stock
2-[1-(4-Piperonyl)piperazinyl]benzothiazole: 10mg Please Inquire In Stock
2-[1-(4-Piperonyl)piperazinyl]benzothiazole: 20mg Please Inquire Please Inquire
2-[1-(4-Piperonyl)piperazinyl]benzothiazole: 50mg Please Inquire Please Inquire
2-[1-(4-Piperonyl)piperazinyl]benzothiazole: 100mg Please Inquire Please Inquire
2-[1-(4-Piperonyl)piperazinyl]benzothiazole: 200mg Please Inquire Please Inquire
2-[1-(4-Piperonyl)piperazinyl]benzothiazole: 500mg Please Inquire Please Inquire
2-[1-(4-Piperonyl)piperazinyl]benzothiazole: 1000mg Please Inquire Please Inquire
Related Products

Quality Control of 2-[1-(4-Piperonyl)piperazinyl]benzothiazole

Number of papers citing our products

Chemical structure

2-[1-(4-Piperonyl)piperazinyl]benzothiazole

3D structure

Chemical Properties of 2-[1-(4-Piperonyl)piperazinyl]benzothiazole

Cas No. 155106-73-3 SDF Download SDF
PubChem ID 127902 Appearance Powder
Formula C19H19N3O2S M.Wt 353.44
Type of Compound N/A Storage Desiccate at -20°C
Solubility Soluble to 10 mM in DMSO with gentle warming
Chemical Name 2-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-1,3-benzothiazole
SMILES C1CN(CCN1CC2=CC3=C(C=C2)OCO3)C4=NC5=CC=CC=C5S4
Standard InChIKey BYHKGNWKJMGHGE-UHFFFAOYSA-N
Standard InChI InChI=1S/C19H19N3O2S/c1-2-4-18-15(3-1)20-19(25-18)22-9-7-21(8-10-22)12-14-5-6-16-17(11-14)24-13-23-16/h1-6,11H,7-10,12-13H2
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

2-[1-(4-Piperonyl)piperazinyl]benzothiazole Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

2-[1-(4-Piperonyl)piperazinyl]benzothiazole Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of 2-[1-(4-Piperonyl)piperazinyl]benzothiazole

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.8293 mL 14.1467 mL 28.2933 mL 56.5867 mL 70.7334 mL
5 mM 0.5659 mL 2.8293 mL 5.6587 mL 11.3173 mL 14.1467 mL
10 mM 0.2829 mL 1.4147 mL 2.8293 mL 5.6587 mL 7.0733 mL
50 mM 0.0566 mL 0.2829 mL 0.5659 mL 1.1317 mL 1.4147 mL
100 mM 0.0283 mL 0.1415 mL 0.2829 mL 0.5659 mL 0.7073 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
 

References on 2-[1-(4-Piperonyl)piperazinyl]benzothiazole

Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats.[Pubmed:15476746]

Eur J Pharmacol. 2004 Oct 19;502(3):205-11.

The contribution of 5-HT (5-hydroxytryptamine) receptor subtypes to the antinociception produced by intrathecal 5-HT in the formalin test was investigated in rats. Intrathecal 5-HT suppressed both phases of behaviors produced by 5% formalin, and this was blocked by antagonists for 5-HT(1B) (3-[3-(Dimethylamino)propyl]-4-hy-droxy-N-[4-(4-pyridinyl)phenyl]benzamide dihydrochloride, GR 55562), 5-HT(2C) (N-ormethylclozapine/8-Chloro-11-(1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine, D-MC), 5-HT3 (1-Methyl-N-(8-methyl-8-azabicyclo[3.2.1]-oct-3-yl)-1H-indazole-3-carboxamide maleate, LY-278,584) and 5-HT4 receptors (4-Amino-5-chloro-2-metho-xy-benzoic acid 2-(diethylamino)ethyl ester hydrochloride, SDZ-205,557), but not the 5-HT(1D) receptor antagonist 3-[4-(4-Chlorophenyl)piperazin-1-yl]-1,1-diphenyl-2-propanol hydrochloride (BRL 15572). The 5-HT(1A) receptor antagonist N-[2-[4-(2-Methoxyphenyl)-1-piperazinyl]-N-2-pyridinyl-cyclohexanecarboxamide maleate (WAY-100635) decreased only the second phase antinociception of 5-HT. Intrathecal administration of agonists for 5-HT(1A) (3-(N,N-Dipropylaminoethyl)-1H-indole-5-carboxamide maleate, Dipropyl-5CT), 5-HT(1B) (7-Trifluoromethyl-4(4-met-hyl-1-piperazinyl)-pyrrolo[1,2-a]quinoxaline maleate, CGS-12066A), 5-HT(2C) (6-Ch-loro-2-(1-piperazinyl)pyrazine hydrochloride, MK 212), 5-HT3 (N-(3-Chlorophenyl)imidodicarbonimidic diamide hydrochloride, m-CPBG) and 5-HT4 receptors (2-[1-(4-Piperonyl)piperazinyl]benzothiazole, BZTZ) suppressed both phases of the formalin response. The results of the present study indicate that spinal 5-HT(1B,) 5-HT(2C,) 5-HT3 and 5-HT4 receptors, but not the 5-HT(1D) receptor, mediate antinociception produced by 5-HT in the formalin test. The relevance of the 5-HT(1A) receptor is less clear because of the different effects of antagonist and agonist.

Synthesis of 2-piperazinylbenzothiazole and 2-piperazinylbenzoxazole derivatives with 5-HT3 antagonist and 5-HT4 agonist properties.[Pubmed:8176710]

J Med Chem. 1994 Apr 29;37(9):1320-5.

New 2-piperazinylbenzothiazole and 2-piperazinylbenzoxazole derivatives were prepared and tested as 5-HT3 receptor antagonists. Some of the new compounds antagonized the effect of 5-HT at the longitudinal muscle myenteric plexus (LMMP) preparation of the guinea pig ileum, and two benzothiazole derivatives, compounds 2e and 2f, were more potent than ondansetron in this regard. However, these two compounds were much weaker than the typical 5-HT3 receptor antagonist as displacers of [3H]BRL-43694 binding to rat cerebral cortex homogenates or as antagonists of the bradycardia response to 5-HT in the anaesthetized rat. Like the prokinetic agent cisapride, some of the new compounds enhanced gastric emptying in rats. Compound 2f not only markedly enhanced gastric emptying but was also a potent agonist at the isolated rat oesophageal tunica muscularis mucosae, a preparation sensitive to 5-HT4 receptor stimulation, and enhanced the twitch response in the LMMP preparation. The latter effect was blocked by a high concentration of tropisetron or by previous desensitization with 5-methoxytryptamine. Compound 2f appears to show a promising pharmacological profile as a potential gastrokinetic agent.

Keywords:

2-[1-(4-Piperonyl)piperazinyl]benzothiazole,155106-73-3,Natural Products,5-HT Receptor, buy 2-[1-(4-Piperonyl)piperazinyl]benzothiazole , 2-[1-(4-Piperonyl)piperazinyl]benzothiazole supplier , purchase 2-[1-(4-Piperonyl)piperazinyl]benzothiazole , 2-[1-(4-Piperonyl)piperazinyl]benzothiazole cost , 2-[1-(4-Piperonyl)piperazinyl]benzothiazole manufacturer , order 2-[1-(4-Piperonyl)piperazinyl]benzothiazole , high purity 2-[1-(4-Piperonyl)piperazinyl]benzothiazole

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: